Atea Pharmaceuticals Atea Pharmaceuticals is a clinical-stage biopharmaceutical company developing direct anti-viral medicines to treat infectious diseases. Atea completed its IPO on the Nasdaq stock market in October 2020. Client Category Public Equity Link https://ateapharma.com/
